|
ERLIN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.17880000100246E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.97559999470798E-08 |
| Normal-vs-Stage2 |
1.884630E-01 |
| Normal-vs-Stage3 |
7.75010000000353E-05 |
| Normal-vs-Stage4 |
1.05569999997446E-06 |
| Stage1-vs-Stage2 |
2.205600E-02 |
| Stage1-vs-Stage3 |
2.462200E-01 |
| Stage1-vs-Stage4 |
6.139000E-01 |
| Stage2-vs-Stage3 |
1.296250E-01 |
| Stage2-vs-Stage4 |
2.294400E-02 |
| Stage3-vs-Stage4 |
1.940760E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.05210000103762E-08 |
| Normal-vs-AfricanAmerican |
1.625090E-04 |
| Normal-vs-Asian |
4.44230000000712E-05 |
| Caucasian-vs-AfricanAmerican |
1.420180E-01 |
| Caucasian-vs-Asian |
6.027800E-01 |
| AfricanAmerican-vs-Asian |
3.437400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.224800E-04 |
| Normal-vs-Female |
1.04599999772859E-08 |
| Male-vs-Female |
1.149790E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.16210000406159E-08 |
| Normal-vs-Age(41-60Yrs) |
1.17489999995612E-06 |
| Normal-vs-Age(61-80Yrs) |
9.448200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.787400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.305000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.991700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.076400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.986200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.081150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.981800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.153600E-01 |
| Classical-VS-Follicular |
3.43359995991221E-09 |
| Classical-VS-Other |
2.537000E-01 |
| Classical-VS-Normal |
3.51300100120966E-11 |
| Tall-VS-Follicular |
1.978190E-03 |
| Tall-VS-Other |
3.369600E-01 |
| Tall-VS-Normal |
2.2866999999982E-05 |
| Follicular-VS-Other |
4.487400E-01 |
| Follicular-VS-Normal |
6.338200E-01 |
| Other-VS-Normal |
4.373600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.185050E-04 |
| Normal-vs-N1 |
2.148300E-02 |
| N0-vs-N1 |
5.866400E-01 |
|
|
